Red Hill To Issue Another NASDAQ Flotation

July 16, 2015 | Red Hill Biopharma is set to issue another flotation on the NASDAQ stock exchange based on a shelf prospectus. Red Hill hopes to raise tens of millions of dollars in its offering. The flotation was underwritten by Nomura, Roth Capital Partners, MLV & Co., and HC Wainwright & Co. Red Hill Biopharma was founded in 2009 and develops drugs for the treatment of stomach ulcers, among other conditions.